These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Rheumatoid arthritis and more. Shader RI Clin Ther; 2014 Jul; 36(7):993-4. PubMed ID: 24998013 [No Abstract] [Full Text] [Related]
44. In Vivo Models of Rheumatoid Arthritis. Grötsch B; Bozec A; Schett G Methods Mol Biol; 2019; 1914():269-280. PubMed ID: 30729470 [TBL] [Abstract][Full Text] [Related]
45. Rheumatoid arthritis and multiple sclerosis: direful siblings, different strategies. Schett G FEBS Lett; 2011 Dec; 585(23):3601-2. PubMed ID: 22033142 [No Abstract] [Full Text] [Related]
46. The use of suppressive agents for the treatment of rheumatoid arthritis. Brooks PM Aust N Z J Med; 1993 Apr; 23(2):193-204. PubMed ID: 8517844 [No Abstract] [Full Text] [Related]
47. Gene polymorphisms and therapy in rheumatoid arthritis. Castañeda S; López-Mejías R; González-Gay MA Expert Opin Drug Metab Toxicol; 2016; 12(3):225-9. PubMed ID: 26756388 [No Abstract] [Full Text] [Related]
48. Apoptosis a relevant therapeutic target in rheumatoid arthritis? Smith MD; Walker JG Rheumatology (Oxford); 2004 Apr; 43(4):405-7. PubMed ID: 14679296 [No Abstract] [Full Text] [Related]
50. Therapeutic effect of cytembena in rheumatoid arthritis. Truhlár P; Machácek P; Smahel O Int J Clin Pharmacol; 1973 Nov; 8(3):189-93. PubMed ID: 4589327 [No Abstract] [Full Text] [Related]
51. Rheumatoid arthritis: Biomarkers of response to TNF inhibition in RA. Ranganathan P Nat Rev Rheumatol; 2015 Aug; 11(8):446-8. PubMed ID: 26077919 [No Abstract] [Full Text] [Related]
52. Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis. American College of Rheumatology Rheumatoid Arthritis Clinical Trials Task Force Imaging Group and Outcome Measures in Rheumatology Magnetic Resonance Imaging Inflammatory Arthritis Working Group Arthritis Rheum; 2013 Oct; 65(10):2513-23. PubMed ID: 23840013 [No Abstract] [Full Text] [Related]
53. [Expression of TNF receptors in rheumatoid arthritis and ankylosing spondylitis]. Heilig B; Pezzutto A; Lukoschek M; Hunstein W Z Rheumatol; 1993; 52(6):383-9. PubMed ID: 8147132 [TBL] [Abstract][Full Text] [Related]
54. [Tailor-made medicine and genomic drug discovery in rheumatoid arthritis]. Taniguchi A; Kamatani N Nihon Rinsho; 2005 Jan; 63 Suppl 1():686-90. PubMed ID: 15799443 [No Abstract] [Full Text] [Related]
55. Rheumatoid arthritis: are current research-based guidelines clinically relevant? Kafaja S; Furst DE J Rheumatol; 2014 Aug; 41(8):1569-70. PubMed ID: 25086136 [No Abstract] [Full Text] [Related]
57. [Studies on the genes related to rheumatoid arthritis and the application of the results to clinical medicine]. Yamamoto K; Suzuki A; Kochi Y; Mori M; Yamada R Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1845-55. PubMed ID: 17929421 [No Abstract] [Full Text] [Related]
58. The use of methotrexate in rheumatoid arthritis. Letendre PW; DeJong DJ; Miller DR Drug Intell Clin Pharm; 1985 May; 19(5):349-58. PubMed ID: 3891280 [TBL] [Abstract][Full Text] [Related]
59. [Cytogenetic characteristics of lymphocytes in children with rheumatoid arthritis]. Kostrova AA; Melikhova NI Pediatriia; 1976 Nov; (11):87-9. PubMed ID: 995554 [No Abstract] [Full Text] [Related]
60. Key randomized trials of single agents in early rheumatoid arthritis. van de Putte LB J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]